• Exolaunch signs contract with SpaceX for Starfall mission.
• Mission targets launch on SpaceX Starship rocket in 2029.
• Exolaunch will serve as payload integrator for microgravity research and in-space manufacturing.
• Demand for microgravity access is growing rapidly, particularly in pharmaceutical development and biotechnology.

This partnership may indicate a significant expansion of Exolaunch's capabilities into microgravity research and in-space manufacturing, which could strengthen its position in the global space market. The collaboration with SpaceX suggests a growing demand for access to microgravity environments, which may drive innovation in pharmaceutical development, biotechnology, and advanced materials.